Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65630 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
O-Desmethyl Mebeverine Acid
CAS:Controlled ProductFormula:C15H23NO3Color and Shape:NeatMolecular weight:265.35Pyrazinecarboxylic Acid-d3
CAS:Controlled Product<p>Applications Labelled analogue of Pyrazinecarboxylic Acid, a very potent urate retaining drug. Pyrazinecarboxylic Acid is a metabolite of the antibacterial agent Pyrazinamide (P840600).<br>References Fanelli, G.M. et al.: J. Clin. Invest., 52, 1946 (1973): Fanelli, G.M. et al.: J. Pharmacol. Exp. Therap., 200, 413 (1977); Lacroix, C. et al.: Arzneim.-Forsch., 40, 76 (1990); Kraemer, H.-J. et al.: J. Chrom. B Niomed. Sci. Appl., 706, 319 (1998);<br></p>Formula:C5HD3N2O2Color and Shape:White To Light YellowMolecular weight:127.12Nevirapine-d3
CAS:Controlled Product<p>Applications Labelled Nevirapine (N391275), a potent (IC50=84nM) and selective non-nucleoside inhibitor of HIV-1 reverse transcriptase. Antiviral.<br>References Hargrave, K.D., et al.: J. Med. Chem., 34, 2231 (1991), Cheeseman, S.H., et al.: Antimicrob. Agents Chemother., 37, 178 (1993), Guay, L.A., et al.: Lancet, 354, 795 (1999),<br></p>Formula:C15H11D3N4OColor and Shape:White To Light BeigeMolecular weight:269.32N-(p-Chlorobenzoyl)-p-anisidine
CAS:Controlled Product<p>Applications N-(p-Chlorobenzoyl)-p-anisidine is a COX-1 inhibitor analgesics that do not cause gastric damage.<br>References Kakuta, H., et al.: J. Med. Chem., 51, 2400 (2008);<br></p>Formula:C14H12ClNO2Color and Shape:White To Off-WhiteMolecular weight:261.77-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
CAS:Controlled Product<p>Applications 7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione is an impurity of Linagliptin (L465900), a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.<br>References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011);<br></p>Formula:C21H21N7O2Color and Shape:NeatMolecular weight:403.4373,5,6-Trihydroxy-1-isopropylindole
CAS:Controlled Product<p>Applications 3,5,6-Trihydroxy-1-isopropylindole is an impurity of Isoproterenol (I874200), which is a non-selective beta-adrenergic agonist. Isoproterenol is used in the treatment of bradycardia; bronchodilator.<br>References Kikkawa, H. et al.: Biol. Pharmac. Bull., 17, 1047 (1994); Kral, P. et al.: Psychopharmacologia, 26, 79 (1972); Giles, R.E. et al.: J. Pharmacol. Exp. Ther., 186, 472 (1973);<br></p>Formula:C11H13NO3Color and Shape:NeatMolecular weight:207.226[4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]phenyl]cyclopropylmethanone
CAS:Controlled Product<p>Applications [4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]phenyl]cyclopropylmethanone is an impurity of Haloperidol (H103700), an antidyskinetic; antipsychotic.<br>References Janicki, C.A., et al.: Anal. Profiles Drug Subs., 9, 341 (1980); Beresford, R., et al.: Drugs, 33, 31 (1987)<br></p>Formula:C21H22ClNO2Color and Shape:NeatMolecular weight:355.86Levofloxacin Ethyl Ester
CAS:Controlled Product<p>Impurity Levofloxacin USP Related Compound C<br>Applications Levofloxacin Ethyl Ester (Levofloxacin USP Related Compound C) is an impurity of Levofloxacin (L360000).<br>References Lalitha Devi, M. et al.: J. Pharrm. Biomed. ANal., 50, 710 (2009); Mehta, J. et al.: Int. J. PharmTech Res., 2, 1932 (2010);<br></p>Formula:C20H24FN3O4Color and Shape:White To Off-WhiteMolecular weight:389.42Fenoterol-d6 Hydrobromide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Labelled Fenoterol (F248850). An β2-adrenergic agonist. Bronchodilator; tocolytic.<br>References Schuster, B., et al. Arzneim.-Forsch., 19, 1905 (1969), Gerris, J., et al.: Eur. J. Clin. Pharmacol., 18, 443 (1980), Heel, R.C., et al.: Drugs, 15, 3 (1978),<br></p>Formula:C17D6H15NO4·BrHColor and Shape:Off White To BrownMolecular weight:390.30(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran
CAS:Controlled Product<p>Applications (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran is used as a reactant in the efficient synthesis of empagliflozin inhibitor of SGLT-2 utilizing AlCl3-promoted silane reduction of β-glycopyranoside.<br>References Wang, X., et al.: Org. Lett., 16, 4090 (2014);<br></p>Formula:C17H16BrClO2Color and Shape:Off-WhiteMolecular weight:367.66O-Desisopropyl-O-methoxyethyl Nimodipine
CAS:Controlled Product<p>Impurity Nimodipine EP Impurity C; Nimodipine USP Related Compound B<br>Applications O-Desisopropyl-O-methoxyethyl Nimodipine (Nimodipine EP Impurity C) is an impurity in the synthesis of Nimodipine (A dihydropyridine calcium channel blocker. It is used as a vasodilator (cerebral). Nimodipine USP Related Compound B.<br>References Allen, G.S., et al.: N. Engl. J. Med., 308, 619 (1983), Schluter, H.: Arzneim.-Forsch., 36, 1733 (1986), Deyo, R.A., et al.: Science, 243, 809 (1989),<br></p>Formula:C21H26N2O8Color and Shape:NeatMolecular weight:434.44R-(-)-Deprenyl Hydrochloride
CAS:Controlled Product<p>Applications Monoamine oxidase-B inhibitor related structurally to Pargyline. Used to alleviate the symptoms of Parkinsons disease.<br>References Magyar, K., et al.: Acta Physiol. Acad. Sci. Hung., 32, 377 (1967), Heinonen, E.H., et al.: Acta Neurol. Scand., 84, 44 (1991), Schneider, L.S., et al.: Am. J. Psychiatry, 150, 321 (1993),<br></p>Formula:C13H17N·ClHColor and Shape:White To Off-WhiteMolecular weight:223.743-Hydroxy Ropivacaine
CAS:Controlled Product<p>Applications A major metabolite of Ropivacaine (R675000).<br>References Ekstrom, G., et al.: Drug Metab. Dispos., 24, 955 (1996), Arvidsson, T., et al.: Biomed. Chromatogr., 13, 286 (1999), Shah, V., et al.: Pharm. Res., 17, 1551 (2000),<br></p>Formula:C17H26N2O2Color and Shape:NeatMolecular weight:290.42,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]
CAS:Controlled Product<p>Applications An impurity in the synthesis of Silodosin (S465000), an α1a-adrenoceptor antagonist. It is used in treatment of benign prostatic hypertophy.<br>References Barve, I. et al.: Tetra., 69, 2834 (2013); Shibata, K., et al.: Mol. Pharmacol., 48, 250 (1995), Murata, S., et al.: J. Urol., 164, 578 (2000),<br></p>Formula:C25H30F3N3O3Color and Shape:Light YellowMolecular weight:477.523’-(2-Fluorophenyl) Ezetimibe
CAS:Controlled Product<p>Impurity Ezetimibe o-Fluorobenzene Isomer (USP)<br>Applications 3’-(2-Fluorophenyl) Ezetimibe is an impurity of Ezetimibe (E975005), an antihyperlipoproteinemic and a cholesterol absorption inhibitor.<br>References van Heek, M., at al.: J. Pharmacol. Exp. Ther., 283, 157 (1997), van Heek, M., at al.: Brit. J. Pharmacol., 129, 1748 (2000)<br></p>Formula:C24H21F2NO3Color and Shape:White To Off-WhiteMolecular weight:409.43Boc-3-hydroxy-1-adamantyl-D-glycine
CAS:Controlled Product<p>Applications Boc-3-hydroxy-1-adamantyl-D-glycine is used in the preparation of a Saxagliptin intermediate.<br>References Hanson, R.L., et. al.: Adv. Scyn. Catal., 349, 1369 (2007)<br></p>Formula:C17H27NO5Color and Shape:NeatMolecular weight:325.4Tazarotene Sulfone
CAS:Controlled Product<p>Applications Tazarotene Sulfone is a derivative of Tazarotene (T010050) that has been used for treating skin disorders.<br></p>Formula:C21H21NO4SColor and Shape:NeatMolecular weight:383.46Diethyl Rivastigmine
CAS:Controlled Product<p>Applications An impurity in Rivastigmine (R541000), a cholinesterase inhibitor.<br>References Tse, F., et al.: Pharm. Res., 15, 1614 (1998), Melchiorre, C., et al.: J. Med. Chem., 47, 5945 (2004), Srinivasu, M., et al.: J. Pharm. Biomed. Anal., 37, 57 (2005),<br></p>Formula:C15H24N2O2Color and Shape:NeatMolecular weight:264.3633Fenfluthrin
CAS:Controlled Product<p>Applications Fenfluthrin can be used in agricultural use and as analyte in analytical/biological study of retrospective screening of relevant pesticide metabolites in food using liquid chromatography high resolution mass spectrometry and accurate-mass databases of parent molecules and diagnostic fragment ions.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Polgar, L., et al.: J. Chromatogr. A., 1249, 83-91 (2012)<br></p>Formula:C15H11Cl2F5O2Color and Shape:Off-WhiteMolecular weight:389.14Mosapride Citric Amide Disodium Salt
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Disodium salt of Mosapride (M731000) derivative.<br>References Yoshida, N., et al.: Arch. Int. Pharmacodyn. Ther., 300, 51 (1989), Yatera, S., et al.: Japan. Pharmacol. Ther., 21, 21 (1993), Ruth, M., et al.: Aliment Pharmacol. Ther., 12, 35 (1998),<br></p>Formula:C27H29ClFN3Na2O9Color and Shape:NeatMolecular weight:639.96rac-Paroxetine-d4 Hydrochloride
CAS:Controlled Product<p>Applications rac-Paroxetine-d4 Hydrochloride is a racemic labeled analogue of Paroxetine Hydrochloride (P205750), a selective serotonin reuptake inhibitor. Used as an antidepressant.<br>References Lassen, J.B.: Eur. J. Pharmacol., 47, 351 (1978); Lund, J., et al.: Acta Pharmacol. Toxicol., 51, 351, (1982)<br></p>Formula:C19H17D4ClFNO3Color and Shape:White To Light BrownMolecular weight:369.85Pefloxacin Mesylate
CAS:Controlled Product<p>Applications Pefloxacin is a fluorinated quinolone antibacterial; analog of Norfloxacin.<br>References Barre, J., et al.: J. Pharm. Sci., 73, 1379 (1984), Contrepois, A., et al.: J. Antimicrob. Chemother., 14, 51 (1984),<br></p>Formula:C17H20FN3O3·CH4O3SColor and Shape:Off-WhiteMolecular weight:429.4610,11-Dihydro-10-hydroxy Carbamazepine-D4 (Major)
CAS:Controlled ProductFormula:C152H4H10N2O2Color and Shape:BrownMolecular weight:258.314-Desmethyl-4-ethylimidazolyl Nilotinib
CAS:Controlled ProductFormula:C29H24F3N7OColor and Shape:Light Beige To Light BrownMolecular weight:543.54Rilpivirine
CAS:Controlled Product<p>Applications A novel non-nucleoside reverse transcriptase inhibitor. Rilpivirine seems to be well tolerated with less CNS disturbance than Efavirenz, and has non-teratogenic potential. An anti-HIV agent.<br>References Sun, et al.: J. Med. Chem., 41, 4648 (1998), Kashiwada, et al.: Bioorg. Med. Chem. Lett., 11, 183 (2001),<br></p>Formula:C22H18N6Color and Shape:YellowMolecular weight:366.42Naloxegol Oxalate
CAS:<p>Applications Naloxegol Oxalate is an oxalate form of Naloxegol (N284470) which is a peripherally-selective opioid antagonist.<br>References Seifert, R., et al.: G Protein-Coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity, 227 (2012)<br></p>Formula:C34H53NO11•C2H2O4Color and Shape:NeatMolecular weight:651.799003Ethyl 1-Benzyl-3-(4-bromophenyl)-1H-pyrazole-5-carboxylate
CAS:Purity:95.0%Molecular weight:385.260986328125(R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5)
CAS:Controlled Product<p>Applications (R)-Crizotinib-d5 (piperidine-3,3,4,5,5-d5) (CAS# 1395950-84-1) is a useful isotopically labeled research compound.<br></p>Formula:C21D5H17Cl2FN5OColor and Shape:NeatMolecular weight:455.3675Palbociclib N-Aldehyde
CAS:Controlled Product<p>Applications Palbociclib N-Aldehyde is an intermediate in synthesizing Palbociclib N-β-D-Glucuronide Sodium Salt (P139910), a derivative of Palbociclib (P139900) which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.<br>References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)<br></p>Formula:C25H29N7O3Color and Shape:NeatMolecular weight:475.54N-(2,3-Dichlorophenyl)piperazine Hydrochloride
CAS:Controlled ProductFormula:C10H12Cl2N2·ClHColor and Shape:WhiteMolecular weight:267.582-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)-3,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one
CAS:Purity:95.0%Molecular weight:273.3399963378906Metaflumizone
CAS:<p>Applications Metaflumizone is a semicarbazone insecticide that works by blocking sodium channel in target insects resulting in paralyzation associated with blocking nerve activity. Metaflumizone is useful as a heartworm control treatment.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Zhang, Zhe,, et al.: J. Integrat. Agri. 11, 1145 (2012); Kuhn, D., et al.: Modern. Crop. Protect. Compound., 3, 1273 (2012);<br></p>Formula:C24H16F6N4O2Color and Shape:WhiteMolecular weight:506.40Dimethylaminomethylfurylmethylthioethyl Ranitidine
CAS:Controlled Product<p>Impurity Ranitidine EP impurity A<br>Applications Dimethylaminomethylfurylmethylthioethyl Ranitidine (Ranitidine EP impurity A) is a Ranitidine (R120000) impurity.<br>References Evans, M., et al.: J. Pharm. Biomed. Anal., 7, 1 (1989), Mellors, J., et al.: Anal. Chem., 76, 5441 (2004),<br></p>Formula:C22H35N5O4S2Color and Shape:NeatMolecular weight:497.675-Methyl-2-phenoxypyridine
CAS:Controlled ProductFormula:C12H11NOColor and Shape:NeatMolecular weight:185.233-(5-Formylfuran-2-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde
CAS:Purity:98%Molecular weight:266.256011962890610-Oxo Mirtazapine (Mirtazapine Impurity F)
CAS:Controlled Product<p>Impurity Mirtazapine EP Impurity F<br>Applications 10-Oxo Mirtazapine (Mirtazapine Impurity F) is an impurity of Mirtazapine. Mirtazapine EP Impurity F.<br>References De Boer, T., et al.: Neuropharmacol., 27, 399 (1988), Vindevogel, J., et al.: Anal. Chem., 63, 1530 (1991), Wynia, G., et al.: J. Chromatogr., 773, 339 (1997),<br></p>Formula:C17H17N3OColor and Shape:NeatMolecular weight:279.345,5',5''-(1,3,5-Triazine-2,4,6-triyl)tris(pyridin-2-amine)
CAS:Purity:95%Color and Shape:SolidMolecular weight:357.3810119628906(3S,3'S)-4,4'-(7-Chloropyrido[2,3-d]pyrimidine-2,4-diyl)bis(3-methylmorpholine)
CAS:Purity:95.0%Molecular weight:363.85000610351564-Hydroxy Omeprazole Sulfide
CAS:Controlled Product<p>Stability Light Sensitive<br>Applications An intermediate in the preparation of Omeprazole metabolites.<br>References Hoffmann, K., et al.: Drug Metab. Disposition, 14, 341 (1986), Andersson, T., et al.: Brit. J. Clin. Pharmacol., 36, 521 (1993),<br></p>Formula:C16H17N3O2SColor and Shape:NeatMolecular weight:315.39(6,7-Dimethyl-3-phenyl-quinoxalin-2-yl)-phenyl-methanone
Purity:95.0%Molecular weight:338.4100036621094Dehydropinaverium Bromide
CAS:<p>Applications 4-[(2-Bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethoxy]ethyl]morpholinium Bromide (1:1), is the derivative of Pinaverium Bromide (P465000), which is spasmolytic agent with low incidence of anticholinergic effects. It is a drug used for functional gastrointestinal disorders.<br>References Jacquot, C., et al.: Eur. J. Med. Chem., 13, 61 (1978), Bretaudeau, J., et al.: J. Pharmacol., 11, 233 (1980), Bertrand, J., et al.: Therapie, 36, 555 (1981),<br></p>Formula:C26H39BrNO4·BrColor and Shape:NeatMolecular weight:589.404’-Hydroxy Toremifene (~8% E isomer)
CAS:Controlled Product<p>Applications 4’-Hydroxy Toremifene is a metabolite of Toremifene (T547500).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Jones, R.M. et al.: Biomed. Chrom., 16, 361 (2002);<br></p>Formula:C26H28ClNO2Color and Shape:NeatMolecular weight:421.961-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1H-indazole-4-carboxamide
CAS:Purity:98%Color and Shape:SolidMolecular weight:569.754028320313Bumadizon
CAS:<p>Applications Bumadizon, is a non-steroidal anti-inflammatory (NSAID) drug.<br>References Okada, Y., et al.: Yakugaku Zasshi, 106, 240 (1986;<br></p>Formula:C19H22N2O3Color and Shape:NeatMolecular weight:326.39Dehydroxy Mirabegron Hydrochloride Salt
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Dehydroxy Mirabegron is an impurity of Mirabegron (M364900), potent bladder relaxant and reagent for diabetes remedy. It can also be used to effectively identify impurity generated during Mirabegron synthesis, so as to control the quality.<br>References Zhang, F., et.al., Faming Zhuanli Shenqing, 15, (2014);<br></p>Formula:C21H24N4OS·(HCl)Color and Shape:NeatMolecular weight:380.51 + (36.46)Benzocaine-d4
CAS:Controlled Product<p>Applications Labelled Benzocaine (B202970). Benzocaine is used as an anesthetic (local).<br>References Ali, S.L., et al.: Anal. Profiles Drug Subs., 12, 73 (1983),<br></p>Formula:C92H4H7NO2Color and Shape:NeatMolecular weight:169.212-Amino-4-(4-cyclohexyl-phenyl)-5-methyl-thiophene-3-carboxylic acid methyl ester
CAS:Molecular weight:329.45999145507815-Hydroxy Dantrolene-d4
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A labelled metabolite of Dantrolene (D185000) that has shown to have muscle relaxant effects.<br>References Ellis, K.O., et al.: J. Med. Chem., 21, 127 (1977), Jayyosi, Z., et al.: Drug Metab. Dispos., 21, 939 (1993),<br></p>Formula:C14H6D4N4O6Color and Shape:NeatMolecular weight:334.28Mizolastine
CAS:<p>Applications A highly selective histamine H1-receptor antagonist (with no anticholinergic, antiadrenergic, or antiserotonin activity) for use in the treatment of allergic disorders, especially rhinitis and urticaria.<br>References Simons, F.E.R.: Clin. Alp. Allergy, 29, 3 (1999); Brostoff, J. et al.: Allergy, 51, 251 (1996); Gensthaler, B.M.: Pharm. Zeit., 143, 228 (1998);<br></p>Formula:C24H25FN6OColor and Shape:NeatMolecular weight:432.491-Benzhydrylpiperazine
CAS:Controlled ProductFormula:C17H20N2Color and Shape:White To BeigeMolecular weight:252.35Des [3-(1-Dimethylamino)ethyl] 3-Acetyl Rivastigmine
CAS:Controlled Product<p>Impurity Rivastigmine EP Impurity C; USP Related Compound D<br>Applications Des [3-(1-dimethylamino)ethyl] 3-acetyl Rivastigmine (Rivastigmine EP Impurity C) is a derivative of Rivastigmine (Tartrate: R541000), and acetylcholinesterase inhibitor that is commonly used to treat dementia associated with Parkinson’s disease and Alzheimer’s disease.<br>References Emre, M., et al.: New. Engl. J. Med., 351, 2509 (2004); Polinsky, R.: Clin. Ther., 20, 634 (1998); Wilkinson, D., et al.: Int. J. Clin. Pract., 56, 441 (2001)<br></p>Formula:C12H15NO3Color and Shape:Off-WhiteMolecular weight:221.25Tetramethylurea
CAS:<p>Applications Tetramethylurea is an excellent solvent for organic substances, in particular aromatic compounds.<br>References Lüttringhaus, A., et al.: Angew. Chem. Int. Ed. Engl., 3, 260 (1964)<br></p>Formula:C5H12N2OColor and Shape:NeatMolecular weight:116.161-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
CAS:Controlled Product<p>Impurity Pethidine impurity B<br>Applications 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine is a dopaminergic neurotoxin that reportedly causes a severe and irreversible Parkinsonian condition in humans and monkeys.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Burns, R.S., et al.: Proc. Natl. Acad.Sci. USA, 80, 4546 (1983), Langston, J.W., et al.: Science, 219, 979 (1983), Mogi, M., et al.: Neurosci. Lett., 250, 25 (1998), Przedborski, S. and Jackson-Lewis, V., Mov. Disord., 13, 35 (1998),<br></p>Formula:C12H15NColor and Shape:NeatMolecular weight:173.25cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl p-Tolylsulfonate
CAS:<p>Impurity Ketoconazole EP Impurity E<br>Applications cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl p-Tolylsulfonate (Ketoconazole EP Impurity E) is an intermediate in the synthesis of the drug Ketoconazole (K186000).<br>References McManus, O., et al.: Biochemistry, 32, 6128 (1993), Olesen, S., et al.: Eur. J. Pharmacol., 251, 53 (1994), Assano, M., et al.: J. Pharm. Exp. Ther., 275, 775 (1995), Hewawasam, P., et al.: J. Med. Chem., 45, 1487 (2002),<br></p>Formula:C21H20Cl2N2O5SColor and Shape:NeatMolecular weight:483.36Vildagliptin-13C5,15N
CAS:Controlled ProductFormula:C1213C5H25N215NO2Color and Shape:NeatMolecular weight:309.366-chloro-2-(3-hydroxyphenyl)quinoline-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:299.7099914550781Regorafenib (Pyridine)-N-oxide
CAS:Controlled Product<p>Stability Light Sensitive<br>Applications Regorafenib (Pyridine)-N-oxide is a synthetic metabolite of Regorafenib (R143000) and is used for treatment and prevention of cancer.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Wilhelm, S.: PCT Int. Appl. WO 2011130728 A1 20111020. Oct 20, 2011<br></p>Formula:C21H15ClF4N4O4Color and Shape:NeatMolecular weight:498.81O-Desmethyl Diltiazem Hydrochloride
CAS:Controlled Product<p>Impurity Diltiazem EP Impurity C (HCl)<br>Applications A metabolite of Diltiazem (D460620), an antianginal, antihypertensive pharmaceutical. Diltiazem EP Impurity C (HCl).<br>References Li, R., et al.: J. Med. Chem., 35, 3246 (1992),<br></p>Formula:C21H25ClN2O4SColor and Shape:NeatMolecular weight:436.95trans-4-Aminocyclohexanol
CAS:<p>Applications trans-4-Aminocyclohexanol, used in the preparation of potential hypertensive agents and other biologically active compounds.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Chan, K.L. et al.: As. J. Pharmacol. Sci., 1, 91 (1979);<br></p>Formula:C6H13NOColor and Shape:NeatMolecular weight:115.174N-Nitroso Nitrofurantoin impurity R
Controlled ProductFormula:C7H6N4O6Color and Shape:NeatMolecular weight:242.145742,7-Bis(pyridin-4-ylmethyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone
CAS:Purity:95%Molecular weight:448.437988281252,5-Bis(2,2,2-trifluoroethoxy)benzoic Acid
CAS:Controlled Product<p>Impurity Flecainide EP Impurity D<br>Applications Flecainide Acetate Impurity D.<br>References Banitt, E., et al.: J. Med. Chem., 18, 1130 (1975),<br></p>Formula:C11H8F6O4Color and Shape:White To Off-WhiteMolecular weight:318.17Benzocaine
CAS:Controlled Product<p>Applications Benzocaine is used as an anesthetic (local).<br>References Kholod, Y., et al.: Environ. Sci. Technol., 43, 9208 (2009), Fliri, A., et al.: J. Med. Chem., 52, 8038 (2009), Perez-Garrido, Alfonso; Helguera, A., et al.: J. Pharm. Sci., 98, 4557 (2009), Onoue, S., et al.: J. Pharm. Sci., 98, 3647 (2009),<br></p>Formula:C9H11NO2Color and Shape:NeatMolecular weight:165.19Cabozantinib (Phenylene-d4) L-Malate Salt
CAS:Controlled Product<p>Applications Cabozantinib-d4 L-Malate Salt, is the labeled analogue of Cabozantinib L-Malate Salt (C051500), which is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and has been shown to reduce tumor growth, metastasis, and angiogenesis.<br>References Camp, R., et al.: Cancer, 86, 2259 (1999), Morello, S., et al.: J. Cell Physiol., 189, 285 (2001), Zhang, Y., et al.: Oncogene, 21, 217 (2002), Wells, S., et al.: J. Clin. Oncol., 28, 767 (2010),<br></p>Formula:C28D4H20FN3O5·C4H6O5Color and Shape:NeatMolecular weight:639.62Selexipag
CAS:Controlled Product<p>Applications Selexipag is an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans.<br>References Kuwano, K., et al.: J. Pharm. Exp. Ther., 322, 1181 (2007);<br></p>Formula:C26H32N4O4SColor and Shape:Light YellowMolecular weight:496.623-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
CAS:Controlled Product<p>Impurity Risperidone EP Impurity L<br>Applications 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (Risperidone EP Impurity L) is an intermediate in the synthesis of Risperidone (R525000), which is a combined serotonin (5-HT2) and dopamine (D2) receptor antagonist.<br>References Jannssen, P.A.J., et al.: J. Pharmacol. Exp. Ther., 244, 685 (1988), Gelders, Y.G., et al.: Pharmacopsychiatry, 23, 206 (1990), Green, B.: Curr. Med. Res. Opin., 16, 57 (2000)<br></p>Formula:C11H15ClN2OColor and Shape:NeatMolecular weight:226.70Ondansetron Hydrochloride Dihydrate
CAS:Formula:C18H19N3O·ClH·2H2OColor and Shape:Off-WhiteMolecular weight:365.85[3-[[[2-(Diaminomethyleneamino)-4-thiazolyl]methyl]thio]propionyl]sulfamide Hydrochloride
CAS:Controlled Product<p>Impurity Famotidine EP Impurity C<br>Applications An intermediate in the synthesis of the metabolite of the drug Famotidine.<br>References Yanagisawa, I., et al.: J. Med. Chem., 30, 1787 (1987), Singh, S., et al.: J. Pharm. Sci., 91, 253 (2002),<br></p>Formula:C8H14N6O3S3·ClHColor and Shape:Off-WhiteMolecular weight:374.89Hydroxy Nefazodone Dihydrochloride
CAS:Controlled Product<p>Applications A metabolite of Nefazodone (N389100), an antidepressant.<br>References Barbhaiya, R., et al.: Eur. J. Clin. Pharmacol., 49, 221 (1995), Greene, D., et al.: Clin. Pharmacokinet., 33, 260 (1997), Kalgutkar, A., et al.: Drug Metab. Dispos., 33, 243 (2005),<br></p>Formula:C25H34Cl3N5O3Color and Shape:NeatMolecular weight:558.93FOY 251
CAS:<p>Applications A metabolite of Camostat. It is a pollen protease inhibitor for prevention and control of allergy.<br>References Senochuki, K., et al.: J. Med. Chem., 38, 2521 (1995)<br></p>Formula:C16H15N3O4·CH4O3SColor and Shape:White SolidMolecular weight:409.414-(Chloromethyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide
CAS:Purity:95+%Molecular weight:429.91000366210944-(2-Keto-1-benzimidazolinyl)piperidine-d5 (Major)
CAS:Controlled Product<p>Applications Labelled 4-(2-Keto-1-benzimidazolinyl)piperidine is an impurity of labelled Pimozide. Pimozide impurity A.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Andersson, L., et al.: J. Lipid Res., 36, 1392 (1995), Andersson, M., et al.: J. Biol. Chem., 2005, 280, 27578 (2005),<br></p>Formula:C12H10D5N3OColor and Shape:NeatMolecular weight:222.33-[[[2-[(Diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications 3-[[[2-[(Diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide hydrochloride (cas# 76833-47-1) is a useful research chemical.<br></p>Formula:C8H14N6S2·ClHColor and Shape:NeatMolecular weight:294.83(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:356.41000366210941-[3-(4-tert-Butylbenzoyl)propyl]-4-hydroxypiperidine
CAS:Controlled ProductFormula:C19H29NO2Color and Shape:WhiteMolecular weight:303.44N-Nitroso Clonidine
CAS:Controlled ProductFormula:C9H8Cl2N4OColor and Shape:NeatMolecular weight:259.09Retigabine
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A new experimental anticonvulsant drug. Anxiolytic.<br>References Dailey, J.W.; et al.: Neuroscience Lett., 195, 77 (1995), Korsgaard, M.P.G., et al.: J. Pharmacol. Exp. Ther., 314, 1, 282 (2005),<br></p>Formula:C16H18FN3O2Color and Shape:NeatMolecular weight:303.33Nitisinone
CAS:<p>Applications Nitisinone is a herbicidal triketone that inhibits 4-hydroxyphenylpyruvate dioxygenase (HPPD), an enzyme involved in plastoquinone biosynthesis in plants and in tyrosine catabolism in mammals. It is used in treatment of inherited tyrosinemia type I.<br>References Lindstedt, S., et al.: Lancet, 340, 813 (1992), Ellis, M.K., et al.: Toxicol. Appl. Pharmacol., 133, 12 (1995), Lock, E.A., et al.: J. Inherited Metab. Dis., 21, 498 (1998),<br></p>Formula:C14H10F3NO5Color and Shape:NeatMolecular weight:329.23Lansoprazole
CAS:<p>Applications Used as a gastric proton pump inhibitor. An antiulcerative. May limit the severity of tuberculosis (see Chem. and Eng. News. p. 28 July 20 (2018)).<br>References Figgitt, D., et al.: Drugs, 60, 925 (2000), Katsuki, H., et al.: Eur. J. Clin. Pharmacol., 57, 709 (2001), Barradell, L.B., et al.: Drugs, 44, 225 (1992), Kim, K., et al.: Clin. Pharmacol. Ther., 72, 90 (2002), Niioka, T., et al.: Ther. Drug Monit., 28, 321 (2006), Chem. and Eng. News. p. 28 July 20 (2018)<br></p>Formula:C16H14F3N3O2SColor and Shape:White To Light BeigeMolecular weight:369.36Tolvaptan-d7
CAS:Controlled Product<p>Applications Labelled Tolvaptan. It is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).<br>References Paterna, S., et al.: Eur. J. Heart Fail, 2, 305 (2000), Udelson, J., et al.: Circulation, 104, 2417 (2001), Goldsmith, S., et al.: J. Am. Coll Cardiol., 46, 1785 (2005), Schrier, R., et al.: N. Engl. J. Med., 355, 2099 (2006),<br></p>Formula:C26H18D7ClN2O3Color and Shape:NeatMolecular weight:455.985-Benzo[1,3]dioxol-5-yl-1 H -pyrazole-3-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:232.19500732421875rac-cis-7-Hydroxy Pramipexole
CAS:Controlled Product<p>Impurity Pramipexole Related Compound G<br>Applications Pramipexole derivative used for the preparation of (S)-Pramipexole via resolution of 2,6-diamino-7-hydroxy-4,5,6,7-tetrahydrobenzothiazole derivatives.<br>References Validation of a column liquid chromatographic method for the analysis of pramipexole and its 5 impurities. Journal of AOAC International (2010), 93(4), 1102-1112. Gegoe, Csaba Lehel; Fejes, Imre; Garaczi, Sandor; Kovacs, Imre; Lukacs, Ferenc; Majercsik, Orsolya; Schneider, Geza. Process for preparation of (S)-pramipexole via resolution of 2,6-diamino-7-hydroxy-4,5,6,7-tetrahydrobenzothiazole derivatives. Eur. Pat. Appl. (2008), 26pp. CODEN: EPXXDW EP 1878731<br></p>Formula:C10H17N3OSColor and Shape:NeatMolecular weight:227.333-Chloro-N-methylpropan-1-amine Hydrochloride
CAS:Controlled Product<p>Applications 3-Chloro-N-methylpropan-1-amine Hydrochloride can be used as reactant/reagent in oxidative metabolism of ferrocene analogs of tamoxifen: characterization and antiproliferative activities of metabolites.<br>References Richard, M. A., et al.: ChemMedChem, 10, 981-990 (2015)<br></p>Formula:C4H10ClN•(HCl)Color and Shape:NeatMolecular weight:107.583646Decarboxyl Ofloxacin
CAS:Controlled Product<p>Impurity Ofloxacin EP Impurity B<br>Applications A degradation product of Oflaxacin (O245750).<br>References Moroi, R. et al.: Kagaku Ryoho no Ryoiki, 5, 1517 (1989); Monk, J.P., et al.: Drugs, 33, 346 (1987); Drlica, K., Curr. Opin. Microbiol. 2, 504 (1990)<br></p>Formula:C17H20FN3O2Color and Shape:NeatMolecular weight:317.36
![[4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]phenyl]cyclopropylmethanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC376630.webp&w=3840&q=75)
![(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB680755.webp&w=3840&q=75)
![2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD449705.webp&w=3840&q=75)
![2-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)-3,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF496304.webp&w=3840&q=75)
![(3S,3'S)-4,4'-(7-Chloropyrido[2,3-d]pyrimidine-2,4-diyl)bis(3-methylmorpholine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF229684.webp&w=3840&q=75)
![[1,1'-biphenyl]-4-yl(2-chloropyridin-4-yl)methanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF614704.webp&w=3840&q=75)
![Des [3-(1-Dimethylamino)ethyl] 3-Acetyl Rivastigmine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD289320.webp&w=3840&q=75)
![cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl p-Tolylsulfonate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD435718.webp&w=3840&q=75)
![2,7-Bis(pyridin-4-ylmethyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF695964.webp&w=3840&q=75)
![3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC366155.webp&w=3840&q=75)
![[3-[[[2-(Diaminomethyleneamino)-4-thiazolyl]methyl]thio]propionyl]sulfamide Hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD416369.webp&w=3840&q=75)
![3-[[[2-[(Diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide Hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD417670.webp&w=3840&q=75)
![1-[3-(4-tert-Butylbenzoyl)propyl]-4-hydroxypiperidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB690390.webp&w=3840&q=75)
![5-Benzo[1,3]dioxol-5-yl-1 H -pyrazole-3-carboxylic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF027887.webp&w=3840&q=75)
